William Blair Estimates StoneX Group Q2 Earnings
Stock analysts at William Blair issued their Q2 2025 earnings estimates for StoneX Group in a research report issued on Wednesday, March 26th. William Blair analyst J. Schmitt forecasts that the ...
William Blair Has Bearish Forecast for Starbucks Q2 Earnings
Equities research analysts at William Blair reduced their Q2 2025 earnings per share estimates for Starbucks in a report ...
Fintel on MSN5d
William Blair Initiates Coverage of Immunic (IMUX) with Outperform Recommendation
Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...
William Blair Keeps Their Hold Rating on Neuronetics (STIM)
William Blair analyst Margaret Kaczor maintained a Hold rating on Neuronetics (STIM – Research Report) today. The company’s shares closed ...
What is William Blair’s Forecast for Neurogene Q1 Earnings?
Stock analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Neurogene in a research ...
Fintel on MSN4d
William Blair Initiates Coverage of StoneX Group (SNEX) with Outperform Recommendation
Fintel reports that on March 26, 2025, William Blair initiated coverage of StoneX Group (NasdaqGS:SNEX) with a Outperform ...
Fintel on MSN6d
William Blair Downgrades AZEK (AZEK)
Fintel reports that on March 24, 2025, William Blair downgraded their outlook for AZEK (NYSE:AZEK) from Outperform to Market ...
William Blair Sticks to Its Buy Rating for Acuity Brands (AYI)
In a report released today, Ryan Merkel from William Blair maintained a Buy rating on Acuity Brands (AYI – Research Report). The company’s ...
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by William Blair Investment Management LLC
William Blair Investment Management LLC reduced its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 11.9% during the ...
Fintel on MSN9d
William Blair Downgrades Valmont Industries (VMI)
Fintel reports that on March 21, 2025, William Blair downgraded their outlook for Valmont Industries (NYSE:VMI) from ...
Q1 Earnings Estimate for NTLA Issued By William Blair
Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Intellia Therapeutics in a research report issued on Wednesday, March 26th. William Blair analyst M. Minter anticipates ...
Army changes course, Palantir to stay prime contractor, says William Blair
William Blair analyst Louie DiPalma says the U.S. Army changed course and put the Army Data Platform 2.0 program on indefinite hold. In 2023, ...